Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $126.24M Activated in VL: True Average Daily Range Avg Daily Range: $0.88 | 3.43% Avg Daily Range (30 D): $0.05 | 3.36% Avg Daily Range (90 D): $0.05 | 3.44% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): .77M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 182 Avg Trade Size (Sh.) (90 D): 181 Institutional Trades Total Inst.Trades: 1,915 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $1.92M Avg Inst. Trade (90 D): $1.92M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.75M Avg Closing Trade (30 D): $5.64M Avg Closing Trade (90 D): $5.64M Avg Closing Volume: 120.63K     News Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Aug 7, 2025 @ 12:28 AM Zentalis (ZNTL) Q2 Loss Narrows 70% Source: Jesterai Jul 1, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Jun 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.26 $-.37 $-.67 Diluted EPS $-2.26 $-.37 $-.67 Revenue $ 26.87M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -162.78M $ -26.87M $ -48.28M Operating Income / Loss $ -182.96M $ -36.06M $ -45.62M Cost of Revenue $ $ $ Net Cash Flow $ .57M $ -4.33M $ 8.03M PE Ratio